Drugs / BCG Vaccine USP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05592223 Comparator | Dec 2022 → Aug 2023 | tuberculosis | Fred Hutchinson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG Vaccine USP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05592223 ↗ |
| Modality | Vaccine | “licensed and available BCG VACCINE USP (TICE® strain)” NCT05592223 ↗ |
| Route | Other | “given an intradermal injection of BCG” NCT05592223 ↗ |